Join us in advancing precision oncology—invest in groundbreaking science that delivers safer, more effective cancer treatments for patients worldwide.
What makes our value proposition unique is the combination of domain expertise and our drive to overcome challenges through scientific methodologies and problem-solving thinking.
This is reflected in our commitment to ambitious therapeutic targets.
Our Core Strengths
Highly qualified scientific and management team with extensive experience
With support from experienced advisory team
Methodology for molecular target selection and antibody characterization
Designed to deliver toxins exclusively to the cancer cells
World-class know-how in recombinant protein engineering and production
Precise characterization of obtained proteins
Experience in the production and testing of Antibody-Drug Conjugates (ADCs)
ADC development with our in-house platform
Our Core Strengths
Highly qualified scientific and management team with extensive experience
With support from experienced advisory team
Methodology for molecular target selection and antibody characterization
Designed to deliver toxins exclusively to the cancer cells
World-class know-how in recombinant protein engineering and production
Precise characterization of obtained proteins
Experience in the production and testing of Antibody-Drug Conjugates (ADCs)
ADC development with our in-house platform
Our Core Strengths
Highly qualified scientific and management team with extensive experience
With support from experienced advisory team
Methodology for molecular target selection and antibody characterization
Designed to deliver toxins exclusively to the cancer cells
World-class know-how in recombinant protein engineering and production
Precise characterization of obtained proteins
Experience in the production and testing of Antibody-Drug Conjugates (ADCs)
ADC development with our in-house platform
About
Onconick specializes in precision oncology, developing new antibody-drug conjugates (ADCs) targeting highly specific novel markers in challenging cancer types.
© 2025 Onconick. All rights reserved.
About
Onconick specializes in precision oncology, developing new antibody-drug conjugates (ADCs) targeting highly specific novel markers in challenging cancer types.
© 2025 Onconick. All rights reserved.
About
Onconick specializes in precision oncology, developing new antibody-drug conjugates (ADCs) targeting highly specific novel markers in challenging cancer types.
© 2025 Onconick. All rights reserved.